Klacid Rm

Clarithromycin, the active ingredient in Klacid Rm, is a macrolide antibiotic presented as an oral dosage form for systemic use. It is employed to treat a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Klacid Rm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic used to manage bacterial infections affecting the respiratory and skin systems. - Community‑acquired pneumonia: clears the infection and improves lung function. - Acute bacterial sinusitis: reduces sinus inflammation and bacterial load. - Skin and soft‑tissue infections: eradicates causative bacteria and promotes healing. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of triple‑therapy regimens. - Bronchitis: alleviates bacterial bronchial infection and associated cough.

Clarithromycin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation. - Headache: mild, self‑limiting. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - QT prolongation: cardiac rhythm disturbances. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile colitis: severe diarrhea with abdominal pain. - Stevens‑Johnson syndrome: mucocutaneous blistering. - Hematologic abnormalities: neutropenia or thrombocytopenia.

Before prescribing Clarithromycin, clinicians should evaluate patient history and potential risk factors. - Pregnancy: Category B – use only if clearly needed. - Breastfeeding: Caution; drug passes into milk, assess infant risk. - Liver impairment: Adjust therapy; monitor hepatic function. - Cardiac risk: Avoid in patients with known QT prolongation or electrolyte disturbances. - Drug‑resistant organisms: Verify susceptibility when possible. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Clarithromycin interacts with several drug classes; careful review is required.

Major Interactions (Avoid): - Statins (e.g., simvastatin, lovastatin): risk of rhabdomyolysis. - Certain antiarrhythmics (e.g., amiodarone): may cause serious QT prolongation. - P‑glycoprotein substrates (e.g., digoxin): increased serum concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Oral contraceptives: reduced efficacy, advise backup contraception. - Antacids containing aluminum or magnesium: may decrease absorption, separate dosing by at least 2 hours.